"AHEAD focuses on the development and application of AI-enabled diagnostic and disease assessment tools to blood cancer treatment.

AHEAD-flow platform is a blood cancer triage platform.

It fully automates clinical flow cytometry data analysis in 7 seconds.

It is designed to help physicians detecting abnormal specimens faster, hence, reduce the clinical decision delay and allowing timely

treatment for patients."

Headquarter Regions
San Francisco Bay Area, West Coast, Western US
Founded Year
Funding Status
CES 2020
Healthcare & Biomedical